{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:54:13Z","timestamp":1781657653638,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021078","name":"Norwegian Institute of Public Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021078","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As one of few countries in Europe, Norway does not offer vaccination against invasive meningococcal disease (IMD) as part of the National Immunization Program for Children (NIP). Instead, adolescents aged 16\u201319 are recommended to consider having the meningococcal ACWY conjugate vaccine (MCV4) if they participate in activities that increase the risk of IMD. Meningococcal vaccination rates in Norway are low compared to vaccines offered through the NIP. Whereas all vaccinations in the NIP are free and organized through schools or municipal health clinics, there is no uniform system in place for the meningococcal vaccine. On the contrary, both administration practices and cost of vaccination vary nationally, with some counties offering the vaccine for free, while others offer the vaccine at a cost of $40\u201380. The aim of this study was to explore adolescents\u2019 awareness, knowledge, and decision-making processes related to meningococcal disease and vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using a semi-structured interview guide, we conducted 18 focus group interviews in the fall of 2022, involving a total of 126 high school seniors in Norway. The participants were asked to share their views, knowledge and experiences regarding invasive meningococcal disease and vaccination. We used NVivo 14 to facilitate the thematic analysis and a codebook analysis approach was conducted to identify themes and patterns in the data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The analysis identified three central themes emerging from the discussions with the adolescents. These emphasize how information, cost, and location and guidance impact the adolescents\u2019 decision-making and ability to get vaccinated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The current organization of MCV4 vaccination in Norway do not meet the needs identified by the adolescents in this study. This results in unequal access to a highly effective vaccine that protects healthy adolescents against a deadly disease. The present study highlights the need to address vaccination disparities and accessibility, as well as increasing awareness and knowledge about meningococcal disease and vaccination to ensure equal access for all adolescents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-27591-y","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:03:22Z","timestamp":1777518202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201dWhy should I pay for this vaccine?\u201d \u2013 Norwegian adolescents views on meningococcal vaccination"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1432-5581","authenticated-orcid":false,"given":"Rebecca Nybru","family":"Gleditsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4437-4093","authenticated-orcid":false,"given":"Sara Viksmoen","family":"Watle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2765-4488","authenticated-orcid":false,"given":"Bo T.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6906-8436","authenticated-orcid":false,"given":"Lisbeth M.","family":"Naess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3317-8203","authenticated-orcid":false,"given":"Lene Kristine","family":"Juvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9411-3070","authenticated-orcid":false,"given":"Trine Skogset","family":"Ofitserova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"1","key":"27591_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s12889-022-12933-3","volume":"22","author":"S Guedes","year":"2022","unstructured":"Guedes S, Bricout H, Langevin E, Tong S, Bertrand-Gerentes I. Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 - a secondary database analysis. BMC Public Health. 2022;22(1):521. https:\/\/doi.org\/10.1186\/s12889-022-12933-3.","journal-title":"BMC Public Health"},{"issue":"6","key":"27591_CR2","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3201\/eid1206.051297","volume":"12","author":"J MacLennan","year":"2006","unstructured":"MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, Evans MR, Cann K, Baxter DN, Maiden MC, Stuart JM, United Kingdom Meningococcal Carriage Group. Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis. 2006;12(6):950\u20137. https:\/\/doi.org\/10.3201\/eid1206.051297.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"27591_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1056\/NEJMoa1900236","volume":"382","author":"HS Marshall","year":"2020","unstructured":"Marshall HS, McMillan M, Koehler AP, Lawrence A, Sullivan TR, MacLennan JM, Maiden MCJ, Ladhani SN, Ramsay ME, Trotter C, Borrow R, Finn A, Kahler CM, Whelan J, Vadivelu K, Richmond P. Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia. N Engl J Med. 2020;382(4):318\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1900236.","journal-title":"N Engl J Med"},{"key":"27591_CR4","unstructured":"European Centre for Disease Prevention and Control. (n.d.). Vaccine Scheduler. https:\/\/vaccine-schedule.ecdc.europa.eu\/."},{"key":"27591_CR5","unstructured":"World Health Organization. Defeating meningitis by 2030: a global road map. 2021. https:\/\/www.who.int\/initiatives\/defeating-meningitis-by-2030."},{"key":"27591_CR6","unstructured":"Norwegian Institute of Public Health. Childhood Immunisation Programme. 2023. https:\/\/www.fhi.no\/en\/id\/vaccines\/childhood-immunisation-programme\/."},{"key":"27591_CR7","unstructured":"Norwegian Institute of Public Health. Statistics for childhood vaccination. 2023. https:\/\/www.fhi.no\/hn\/helseregistre-og-registre\/sysvak\/barnevaksinasjon---statistikk\/."},{"key":"27591_CR8","doi-asserted-by":"publisher","first-page":"127809","DOI":"10.1016\/j.vaccine.2025.127809","volume":"66","author":"BT Hansen","year":"2025","unstructured":"Hansen BT, \u00d8stlie IB, Greve-Isdahl M, Gleditsch RN. Determinants of parental readiness for childhood vaccination: experiences, information, sociodemographics and adherence. Vaccine. 2025;66:127809. https:\/\/doi.org\/10.1016\/j.vaccine.2025.127809.","journal-title":"Vaccine"},{"issue":"8","key":"27591_CR9","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1080\/21645515.2021.1880209","volume":"17","author":"SV Watle","year":"2021","unstructured":"Watle SV, N\u00e6ss LM, Tunheim G, Caugant DA, Wisl\u00f8ff T. Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine. Hum Vaccines Immunotherapeutics. 2021;17(8):2777\u201387. https:\/\/doi.org\/10.1080\/21645515.2021.1880209.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"2","key":"27591_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/1468-4446.12189","volume":"67","author":"EG Fj\u00e6r","year":"2016","unstructured":"Fj\u00e6r EG, Pedersen W, Sandberg S. Party on wheels: mobile party spaces in the Norwegian high school graduation celebration. Br J Sociol. 2016;67(2):328\u201347. https:\/\/doi.org\/10.1111\/1468-4446.12189.","journal-title":"Br J Sociol"},{"key":"27591_CR11","unstructured":"Mohn EB. This is the cost of the russ celebration \u2013 have given up on a savings account. [Dette kostet russetiden: \u2013 Har gitt opp sparekonto]. VG. 2024. Available from: https:\/\/www.tv2.no\/nyheter\/innenriks\/dette-kostet-russetiden-har-gitt-opp-sparekonto\/16688200\/. Cited 2024 Oct 4."},{"key":"27591_CR12","unstructured":"Norwegian Institute of Public Health. Young people and vaccine against meningococcal vaccine. 2024. https:\/\/www.fhi.no\/en\/id\/meningococcal-disease\/vaksine-mot-smittsom-hjernehinnebetennelse\/young-people-and-vaccine-against-meningococcal-disease\/."},{"key":"27591_CR13","unstructured":"Five ML. Sykdommen kan v\u00e6re d\u00f8delig - likevel f\u00e5r ikke alle vaksinen gratis. Tv2. 2022. Available from: https:\/\/www.tv2.no\/nyheter\/innenriks\/sykdommen-kan-vaere-dodelig-likevel-far-ikke-alle-vaksinen-gratis\/15272031\/."},{"issue":"9","key":"27591_CR14","doi-asserted-by":"publisher","first-page":"e0001109","DOI":"10.1371\/journal.pgph.0001109","volume":"2","author":"H Mitchell","year":"2022","unstructured":"Mitchell H, Lim R, Gill PK, Dhanoa J, Dub\u00e9 \u00c8, Bettinger JA. What do adolescents think about vaccines? Systematic review of qualitative studies. Plos Global Public Health. 2022;2(9):e0001109. https:\/\/doi.org\/10.1371\/journal.pgph.0001109.","journal-title":"Plos Global Public Health"},{"issue":"7\u20138","key":"27591_CR15","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1080\/21645515.2019.1571891","volume":"15","author":"R Herman","year":"2019","unstructured":"Herman R, McNutt L-A, Mehta M, Salmon DA, Bednarczyk RA, Shaw J. Vaccination perspectives among adolescents and their desired role in the decision making process. Hum Vaccines Immunotherapeutics. 2019;15(7\u20138):1752\u20139. https:\/\/doi.org\/10.1080\/21645515.2019.1571891.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"1","key":"27591_CR16","doi-asserted-by":"publisher","first-page":"CD011895","DOI":"10.1002\/14651858.CD011895.pub2","volume":"1","author":"LH Abdullahi","year":"2020","unstructured":"Abdullahi LH, Kagina BM, Ndze VN, Hussey GD, Wiysonge CS. Improving vaccination uptake among adolescents. Cochrane Database Syst Reviews. 2020;1(1):CD011895. https:\/\/doi.org\/10.1002\/14651858.CD011895.pub2.","journal-title":"Cochrane Database Syst Reviews"},{"issue":"4","key":"27591_CR17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.vaccine.2018.11.078","volume":"37","author":"NE Basta","year":"2019","unstructured":"Basta NE, Becker AB, Li Q, Nederhoff D. Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens. Vaccine. 2019;37(4):670\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.078.","journal-title":"Vaccine"},{"issue":"18","key":"27591_CR18","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.vaccine.2014.02.054","volume":"32","author":"B Wang","year":"2014","unstructured":"Wang B, Clarke M, Afzali HHA, Marshall H. Community, parental and adolescent awareness and knowledge of meningococcal disease. Vaccine. 2014;32(18):2042\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.054.","journal-title":"Vaccine"},{"issue":"1","key":"27591_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/14760584.2023.2211163","volume":"22","author":"I Ballalai","year":"2023","unstructured":"Ballalai I, Dawson R, Horn M, Smith V, Bekkat-Berkani R, Soumahoro L, Vicic N. Understanding barriers to vaccination against invasive meningococcal disease: a survey of the knowledge gap and potential solutions. Expert Rev Vaccines. 2023;22(1):457\u201367. https:\/\/doi.org\/10.1080\/14760584.2023.2211163.","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"27591_CR20","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.3201\/eid2607.191812","volume":"26","author":"M de Vries","year":"2020","unstructured":"de Vries M, Claassen L, te Wierik MJM, Coban F, Wong A, Timmermans DRM, Timen A. Meningococcal W135 Disease Vaccination Intent, the Netherlands, 2018\u20132019. Emerg Infect Dis. 2020;26(7):1420\u201329. https:\/\/doi.org\/10.3201\/eid2607.191812.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"27591_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jadohealth.2016.06.004","volume":"59","author":"L Breakwell","year":"2016","unstructured":"Breakwell L, Vogt TM, Fleming D, Ferris M, Briere E, Cohn A, Liang JL. Understanding Factors Affecting University A Students\u2019 Decision to Receive an Unlicensed Serogroup B Meningococcal Vaccine. J Adolesc Health. 2016;59(4):457\u201364. https:\/\/doi.org\/10.1016\/j.jadohealth.2016.06.004.","journal-title":"J Adolesc Health"},{"issue":"2","key":"27591_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/0017896918796049","volume":"78","author":"KMA Trayner","year":"2018","unstructured":"Trayner KMA, Anderson N, Cameron JC. A mixed-methods study to identify factors associated with MenACWY vaccine uptake, barriers and motivations towards vaccination among undergraduate students. Health Educ J. 2018;78(2):189\u2013202. https:\/\/doi.org\/10.1177\/0017896918796049.","journal-title":"Health Educ J"},{"issue":"8","key":"27591_CR23","doi-asserted-by":"publisher","first-page":"e0181817","DOI":"10.1371\/journal.pone.0181817","volume":"12","author":"S Blagden","year":"2017","unstructured":"Blagden S, Seddon D, Hungerford D, Stanistreet D. Uptake of a new meningitis vaccination programme amongst first-year undergraduate students in the United Kingdom: A cross-sectional study. PLoS ONE. 2017;12(8):e0181817. https:\/\/doi.org\/10.1371\/journal.pone.0181817.","journal-title":"PLoS ONE"},{"issue":"1","key":"27591_CR24","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1186\/s12889-023-15872-9","volume":"23","author":"C Oostdijk","year":"2023","unstructured":"Oostdijk C, Ferreira JA, Ruijs WLM, Mollema L, Van Zoonen K. Adolescent and parental decision-making for the MenACWY vaccination: influential predictors and parental-adolescent differences among households in the Netherlands. BMC Public Health. 2023;23(1):947. https:\/\/doi.org\/10.1186\/s12889-023-15872-9.","journal-title":"BMC Public Health"},{"issue":"34","key":"27591_CR25","doi-asserted-by":"publisher","first-page":"5516","DOI":"10.1016\/j.vaccine.2020.05.087","volume":"38","author":"PDOB Lima","year":"2020","unstructured":"Lima PDOB, van Lier A, de Melker H, Ferreira JA, van Vliet H, Knol MJ. MenACWY vaccination campaign for adolescents in the Netherlands: Uptake and its determinants. Vaccine. 2020;38(34):5516\u201324. https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.087.","journal-title":"Vaccine"},{"issue":"8","key":"27591_CR26","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/vaccines10081287","volume":"10","author":"A Webb","year":"2022","unstructured":"Webb A, Gogoi M, Weidman S, Woolf K, Zavala M, Ladhani SN, Pareek M, Gies L, Bayliss CD. Cross-Sectional Study of University Students\u2019 Attitudes to \u2018On Campus\u2019 Delivery of COVID-19, MenACWY and MMR Vaccines and Future-Proofing Vaccine Roll-Out Strategies. Vaccines. 2022;10(8):1287. https:\/\/doi.org\/10.3390\/vaccines10081287.","journal-title":"Vaccines"},{"key":"27591_CR27","unstructured":"Andersen PL, Pedersen W, Bakken A. Russetid i Oslo. Hvem deltar? Hvem feirer hardest? In: Ljunggren J, editor. Oslo Ulikhetenes by. Oslo: Cappelen Damm; 2017. p. 307\u201323."},{"key":"27591_CR28","unstructured":"Nrk. (2023, May 3). L\u00e6rerstreiken. NRK. Accessed: April 15, 2026. Available from: https:\/\/www.nrk.no\/nyheter\/laererstreiken-1.11492948."},{"key":"27591_CR29","unstructured":"Creswell JW, Poth CN. Qualitative Inquiry and Research Design: Choosing Among Five Approaches. 4th ed. Thousand Oaks: Sage; 2018."},{"key":"27591_CR30","unstructured":"Krueger RA, Casey MA. Focus groups: a practical guide for applied research. 5th ed. Thousand Oaks: Sage; 2015."},{"issue":"4","key":"27591_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/14760584.2018.1456921","volume":"17","author":"AR Maisonneuve","year":"2018","unstructured":"Maisonneuve AR, Witteman HO, Brehaut J, Dub\u00e9 \u00c8, Wilson K. Educating children and adolescents about vaccines: a review of current literature. Expert Rev Vaccines. 2018;17(4):311\u201321. https:\/\/doi.org\/10.1080\/14760584.2018.1456921.","journal-title":"Expert Rev Vaccines"},{"key":"27591_CR32","doi-asserted-by":"crossref","unstructured":"Braun V, Clarke V. Thematic Analysis: A Practical Guide. Thousand Oaks: Sage; 2022.","DOI":"10.1007\/978-3-319-69909-7_3470-2"},{"key":"27591_CR33","unstructured":"Boyatzis RE. Transforming Qualitative Information: Thematic Analysis and Code Development. Thousand Oaks: Sage; 1998."},{"issue":"3","key":"27591_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.apnr.2006.08.005","volume":"21","author":"ME Fonteyn","year":"2008","unstructured":"Fonteyn ME, Vettese M, Lancaster DR, Bauer-Wu S. Developing a codebook to guide content analysis of expressive writing transcripts. Appl Nurs Res. 2008;21(3):165\u20138. https:\/\/doi.org\/10.1016\/j.apnr.2006.08.005.","journal-title":"Appl Nurs Res"},{"issue":"5","key":"27591_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.vaccine.2015.11.075","volume":"34","author":"HS Marshall","year":"2015","unstructured":"Marshall HS, Chen G, Clarke M, Ratcliffe J. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment. Vaccine. 2015;34(5):671\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.075.","journal-title":"Vaccine"},{"key":"27591_CR36","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1016\/j.vaccine.2014.04.046","volume":"32","author":"K Taylor","year":"2014","unstructured":"Taylor K, Stocks A, N., Marshall HS. The missing link: Family physician perspectives on barriers andenablers to prescribing a new Meningococcal B vaccine and other recommended, non-government funded vaccines. Vaccine. 2014;32:4214\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.046.","journal-title":"Vaccine"},{"issue":"30","key":"27591_CR37","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1016\/j.vaccine.2015.05.073","volume":"33","author":"S Le Ngoc Tho","year":"2015","unstructured":"Le Ngoc Tho S, Ader F, Ferry T, Floret D, Arnal M, Fargeas S, Chidiac C, Valour F. Vaccination against serogroup B Neisseria meningitidis: Perceptions and attitudes of parents. Vaccine. 2015;33(30):3463\u201370. https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.073.","journal-title":"Vaccine"},{"key":"27591_CR38","doi-asserted-by":"publisher","unstructured":"Packnett ER, Zimmermann NM, Noby P, Morgan LC, Chime N, Ghaswalla P. Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis. Hum Vaccines Immunotherapeutics. 2023;19(1). https:\/\/doi.org\/10.1080\/21645515.2023.2165382.","DOI":"10.1080\/21645515.2023.2165382"},{"key":"27591_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijid.2023.04.005","volume":"131","author":"OB Brynildsrud","year":"2023","unstructured":"Brynildsrud OB, Watle SV, Alfsnes K, Caugant DA. Invasive meningococcal disease in Norway in the two decades before the COVID-19 pandemic. Int J Infect Dis. 2023;131:130\u20139. https:\/\/doi.org\/10.1016\/j.ijid.2023.04.005.","journal-title":"Int J Infect Dis"},{"issue":"18","key":"27591_CR40","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.vaccine.2015.11.065","volume":"34","author":"A Thomson","year":"2016","unstructured":"Thomson A, Robinson K, Vall\u00e9e-Tourangeau G. The 5As: A practical taxonomy for the determinants of vaccine uptake. Vaccine. 2016;34(18):1018\u201324. https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.065.","journal-title":"Vaccine"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27591-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27591-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27591-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:18:09Z","timestamp":1781655489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27591-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27591"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27591-y","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"10 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A data Protection Impact Assessment (DPIA) was prepared by the researchers. As required by the Norwegian Institute of Public Health (NIPH) research conduct procedures, the DPIA was reviewed and recommended by the data protection officer at the NIPH and subsequently approved by the department leader. Written informed consent was obtained from all participants prior to the focus group interviews. All participants were above 16 years of age, thus no parental consent was needed. Ethical approval from the Norwegian Regional Committees for Medical and Health Research Ethics was not required because the purpose of the study was not within the scope of the Norwegian Health Research Act.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1875"}}